996 Combination therapy of peginterferon alfa-2A (40KD) (PEGASYS(R)) and ribavirin (COPEGUS(R)) significantly enhance sustained virological and biochemical response rate in chronic hepatitis C genotype 4 patients in Saudi Arabia

Autor:	A. Sandokji, F Serebour, L Skakni, O Shobokshi, M. Al-Quaiz, T. Dinish, A. Sabah, K. Qahtani, A.O. Tantawi, N. Al-Jasser
Rok vydání:	2003
Předmět:	Response rate (survey) medicine.medical_specialty Hepatology Combination therapy business.industry Ribavirin Virology Gastroenterology chemistry.chemical_compound chemistry Chronic hepatitis Internal medicine Genotype medicine business Peginterferon alfa-2a medicine.drug
Zdroj:	Hepatology. 38:636-636
ISSN:	0270-9139
DOI:	10.1016/s0270-9139(03)81034-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::284499cd0e877737240d625a9f25d4d2 https://doi.org/10.1016/s0270-9139(03)81034-0 Zobrazit plný text záznamu Plný text